Mindful Walking in Low Back Pain

Not Applicable

Completed

• Conditions: Chronic Low Back Pain

• Registration Number: NCT01893073
• Lead Sponsor: Charite University, Berlin, Germany

Brief Summary

The purpose of this study is to determine whether a mindful walking program is effective in the treatment of patients with chronic low back pain.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-06
• Study First Submitted: 2013-07-02
• Study First Submitted QC: 2013-07-05
• Study First Posted: 2013-07-08
• Status Verified: 2014-03
• Primary Completion: 2014-03
• Last Update Submitted: 2014-03-25
• Last Update Posted: 2014-03-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

• male and female, 18-65 years
• chronic low back pain (disease duration > 3 months)
• pain intensity on visual analogue scale at inclusion > 40 mm (0-100 mm scale)
• only pharmacological treatment with NSAID or no treatment in the last 4 weeks
• undersigned informed consent form

Exclusion Criteria

• active walking or jogging in the last 6 weeks (< 60 minutes/week)
• regular meditation, relaxation exercise, mindfulness exercise in last 6 weeks (> 30 minutes per week)
• use of complementary medicine therapies as acupuncture, homeopathy, herbal medicine in last 6 weeks or planned in the next 12 weeks
• use of other nonpharmacological therapies as physical therapy, manual therapy or osteopathy in the last 4 weeks
• participation in another trials within the last 3 months
• pathological neurological symptoms such as muscular paralysis or paraesthesia due to spinal disc herniation or other causes
• risk of falls and inability to walk
• angina pectoris in the last 3 months
• chronic respiratory disease with respiratory insufficiency
• intake of central nervous system-acting analgesics in the last 6 weeks
• Known renal and / or hepatic diseases
• Severe organic, psychological or psychiatric disorders that are not permitting a study participation
• applying for early retirement due to low back pain
• no undersigned informed consent form

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Pain intensity on visual analogue scale	8 weeks

Secondary Outcome Measures

Name	Time	Method
Back function - FFbH-R-Questionnaire	8 weeks, 12 weeks
Pain intensity on visual analogue scale	12 weeks
Cohens perceived stress scale	8 weeks, 12 weeks
Intake of paracetamol	8 weeks
Adverse events	8 weeks, 12 weeks
Quality of Life - SF 36	8 weeks, 12 weeks

Trial Locations

Locations (1)

Institute for Social Medicine, Epidemiology and Health Economics, Charité Universitätsmedizin Berlin, Germany; 🇩🇪 Berlin, Germany